01 26ARDELYX INC
01 48541448
02 48969377
03 19006281
04 19408840
05 610272079
06 610940146
07 412016856
01 12Y
02 14Blank
01 12Y
02 14Blank
01 92029-12-30
02 12030-05-02
03 42033-08-01
04 122034-04-10
Patent Expiration Date : 2030-05-02
US Patent Number : 9006281
Drug Substance Claim :
Drug Product Claim :
Application Number : 211801
Patent Use Code : U-2626
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2030-05-02
Patent Expiration Date : 2029-12-30
US Patent Number : 9408840
Drug Substance Claim :
Drug Product Claim :
Application Number : 211801
Patent Use Code : U-2626
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2029-12-30
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-381
Delist Requested :
Patent Use Description : TREATMENT OF HYPERPHOS...
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-3736
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-3736
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-3736
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-381
Delist Requested :
Patent Use Description : TREATMENT OF HYPERPHOS...
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10940146
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-381
Delist Requested :
Patent Use Description : TREATMENT OF HYPERPHOS...
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10272079
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-381
Delist Requested :
Patent Use Description : TREATMENT OF HYPERPHOS...
Patent Expiration Date : 2034-04-10
Patent Expiration Date : 2034-04-10
US Patent Number : 10272079
Drug Substance Claim :
Drug Product Claim :
Application Number : 213931
Patent Use Code : U-3736
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-04-10
